| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | NuvaRing | FAERS: 8 | US FAERS | |
| 2 | Bosentan | FAERS: 3 | US FAERS | |
| 3 | apixaban | FAERS: 3 | US FAERS | |
| 4 | Zoledronic Acid | FAERS: 2 | US FAERS | |
| 5 | ambrisentan | FAERS: 2 | US FAERS | |
| 6 | Alendronate | FAERS: 1 | US FAERS | |
| 7 | Atorvastatin | FAERS: 1 | US FAERS | |
| 8 | Clozapine | FAERS: 1 | US FAERS | |
| 9 | Dabigatran | FAERS: 1 | US FAERS | |
| 10 | Oxymorphone | FAERS: 1 | US FAERS | |
| 11 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 12 | Terbinafine | FAERS: 1 | US FAERS | |
| 13 | treprostinil | FAERS: 1 | US FAERS | |
| 14 | Deferasirox | OFFSIDES | ||
| 15 | Fluorouracil | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.